Abstract
We thank Srinivasan et al. for the interest in our article.1 We agree that the use of levetiracetam is rational and stated so in the last paragraph of the article.1 Separately, Srinivasan et al. state that clinicians “appreciate the futility of using prophylactic” seizure medications. It is not clear how best to reconcile the rational and common use of levetiracetam with the potential futility of this approach. Definitive clinical trials are needed to determine whether prophylactic seizure medications alter patient outcomes and the occurrence of seizures in high-risk patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
